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INTRODUCTION 
Stroke has now become the second leading cause of death 
worldwide.13 Stroke is an important cause for prolonged disability.1 Given 
this immense burden that stroke exerts, there becomes the need to 
develop more precise estimates of a stroke survivors prognosis and it 
remains an very important goal. And also identification of predictors of 
mortality is very vital so that we can institute many prompt therapeutic 
measures to improve outcome. 
Serum calcium levels play a very significant role in the molecular 
pathway involving ischemic neuronal death and damage. Calcium has 
been studied with relationship to stroke risk factors and stroke 
incidence.27It has been demonstrated in many studies that calcium levels 
are seen decreased in cerebral ischemia. Usually cerebral ischemia causes 
shifting of calcium from extracellular space to intracellular compartment. 
This intracellular calcium accumulated leads to neuronal damage by 
triggering cytotoxic events. 
Serum albumin acts as a unique multifunctional protein and it has 
many neuroprotective effects. 30 There is many growing evidence of its 
prognostic significance in acute ischemic stroke.32 
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Albumin has many intravascular effects. It decreases erythrocyte 
sedimentation under conditions of no flow. Albumin acts as a important 
antioxidant agent. Its one of the neuroprotective property is the 
antagonism of stagnation, thrombosis, and adhesion of leucocytes within 
postcapillary microcirculation. 
This study to determine the prognostic value of serum calcium and 
serum albumin in predicting the severity and functional outcome in 
patients of acute ischemic stroke. 
 
 
 
 
 
 
 
 
 
 
AIMS AND OBJECTIVES 
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AIMS AND OBJECTIVE 
To study the corrected serum calcium and serum albumin in acute 
ischemic stroke. 
To assess the role of corrected serum calcium and serum albumin 
in predicting the severity and short term functional outcome in acute 
ischemic stroke using NIHSS and modified rankin scale. 
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REVIEW OF LITERATURE 
 
Before several centuries, Hippocrates describes stroke as  apoplexy  
means – “thunder struck ,sudden depriving of one’s  sense”. He said 
people of ages between 40-60 are at more risk when compared to other 
fellow person.1 In AD 131,Galen based on his dissections of animals, was  
first person to describe the structure of the brain and its anatomy and  
blood supply. 
Johann Jacob Wepfer (1620- 1695) dissected corpses in the morgue 
and pinpointed that the sudden onset of this apoplexy is due to disruption 
of blood supply to brain. He said that apart from occlusion of the vessels, 
bleeding from the vessels in the brain was an important cause of  this 
apoplexy.1He was the first person to clearly differentiate between 
ischemic and hemorrhagic stroke. 
Thomas Wills (1621-1675), a neuro-anatomist  proposed about the 
cerebral blood vessel anastomoses at the base of brain(CEREBRAL 
ANASTOME), and it was named after him – CIRCLE OF WILLIS. He 
too describes transient ischemicattacks and existence of occlusion of 
carotid artery, the embolus as etiology for stroke. 
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John Abercrombie published paper on this apoplexy and he pointed 
headache, stupor, paralysis are the features of apoplexy.1 Following 
this,several studies were done and different  other stroke syndromes were 
established. During 20th century, there were several advanced technology 
allowing better visualization about the brain anatomy and their functions, 
and about the pathological lesions affecting the brain. 
             Antonio Egas  Moniz (1874-1955), a neurosurgeon,developer of 
cerebral angiography. He surgically exposed and ligated  cranial artery in 
neck, then 30% sodium iodide was injected and then skull films were 
taken at regular intervals. Seldinger, from Sweden, introduced modern 
angiography, in which a small catheter  was introduced into artery over 
flexible guide wire after withdrawing the needle. 
                In 1960, Hounsfield from Britain, introduced the concept of 
Computed Tomography (CT). About mid 1980, MRI proved to be 
superior to CT in picking up the old hemosiderin containing 
hemorrhages, lesion in posterior cranial fossa,vascular malformation, 
lesion abutting on bony surfaces.   
               Franklin, in 1961, pointed the uses of ultrasound in imaging the 
extra cranial carotid vessels. About the end of 20th century, advanced 
imaging technique with CT, MRI spectroscopy helped in the 
localisations, severity and potential reversibility of  cerebral ischemia. 
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Vascular lesions can be visualised better by  CT and  MR angiography.1,2 
These advancement will help in better management of the stroke  in 
upcoming future. 
BLOOD  SUPPLY OF BRAIN     
Brain is supplied by                                           
Internal carotid artery                       
           Vertebral artery 
 
Internal carotid arteries 
They arises from common carotid arteries and enter middle cranial 
fossa through the carotid canal which opens in the side of foramen 
lacerum .It turns upwards to reach the side of body of sphenoid bone.It 
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then turns forward in the cavernous sinus to reach the medial aspect of 
anterior clinoid process and lies lateral to optic chiasma. Its course 
follows a series of bends (carotid siphon). 
BRANCHES   
Hypophyseal arteries 
           Ophthalmic artery 
           Anterior choroidal artery 
           Anterior cerebral artery 
           Posterior communicating artery 
           Middle cerebral artery 
Ophthalmic artery is first branch from internal carotid artery, which 
supplies eye and other structures in the orbit. 
 Posterior communicating artery is the next branch, and it runs back 
to join the posterior cerebral artery, and supplying optic chiasma, optic 
tract, hypothalamus, midbrain, thalamus. 
Anterior choroidal artery  - which arises from distal region of ICA 
and it supplies the internal capsule,  basal ganglia, thalamus, lateral 
geniculate body, optic tract, midbrain, proximal optic radiation. 
Middle cerebral artery- it enters sylvian fissure, before it enters it 
gives deep cerebral branches (Lenticulostriate branches). The middle 
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cerebral artery, in the sylvian fissure, divides into superior & inferior 
division and supplies the lateral part of the cerebral cortex. The 
lenticulostriate branches supply the, internal capsule (posterior limb),  
putamen and outer globus pallidus. 
Anterior cerebral artery –it passes medially above the optic nerve 
and then passes in to the great longitudinal fissure between the frontal 
lobe where it joins the corresponding vessels of the opposite side by 
anterior communicating artery. It follows the curvature of corpus 
callosum and ramifies over medial surface of frontal and parietal lobe and 
supply them.Also supply a narrow lateral band of frontal and parietal 
cortices.The territory supplied by it includes motor sensory cortices for 
the lower limb. 
VERTEBRAL ARTERY 
Vertebral artery arises from the first part of subclavian artery, then 
ascends through the transverse foramina of upper  6  cervical vertebrae, 
then it join with the vertebral artery of the other side to form  basilar 
artery. Its branches includes – anterior spinal artery, posterior spinal 
artery, PICA (posterior inferior cerebellar   artery), small penetrating 
branches to medulla. PICA supplies inferior vermis, inferior and posterior  
surfaces of the cerebellum, brainstem. 
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Basilar artery ascends to the pons  and in the inter-peduncular 
cistern and  it divides into posterior cerebral artery. The other branches of  
it are  
• Labyrinthine artery      
• AICA (anterior inferior cerebellar artery) which supply the 
rostral  cerebellum, brainstem, inner ear 
• the superior cerebellar artery ,supplying the brainstem, 
cerebellar hemisphere(superior part) ,vermis, dentate nucleus  
• posterior cerebral artery. 
The posterior cerebral artery, which winds  around the midbrain 
near the occulomotor nerve. It supplies temporal lobe (inferior part), 
occipital lobe. Its deep branches supply mainly midbrain, thalamus, 
hypothalamus, and geniculate bodies ( thalamostriate branches). 
CIRCLE OF WILLIS 
It is an arterial anastomosis in the interpeduncular  fossa, formed 
anteriorly by two ACA (anterior cerebral artery), which is  connected by 
anterior communicating artery anteriorly, posteriorly by two PCA 
(posterior cerebral artery), communicating with anterior circulation by the 
posterior communicating artery. 
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COLLATERAL BLOOD SUPPLY IN THE BRAIN 
             Usually the anterior two-third of the cerebral circulation is  by the 
internal carotid artery and the posterior one – third is  by  vertebral artery. 
In blood vessels occlusion, collateral develop distal to the site of 
occlusion. collateral development  depends on the vessels occluded, and 
also whether other artery are free of disease or not. 
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Venous drainage of the brain 
1. Superficial cerebral veins 
2  Deep cerebral veins 
Both these veins drains into the dural venous sinuses. It further 
drains into the internal jugular vein. The cerebral veins are valveless and 
they are thin walled, & the blood flow in these veins are in the same 
direction as that of nearby arteries.4 
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EPIDEMIOLOGY OF THE STROKE 
PREVALENCE OF STROKE   
The first community based study of stroke was carried out in 
vellore between 1968 and 1969. Second one was in Rohtak during 1971-
1974.There is 38% increase in stroke among women from year 1975-78 
and 1983-85.7 
PREVALANCE RATE FOR STROKE IN INDIA (RURAL)  
(1970-2004) 
 
 
14 
 
PREVALANCE RATE FOR STROKE IN  INDIA (URBAN) 
(1973-2004) 
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According  to India stroke factsheet updated in 2012, 
Prevelance of stroke - 84 to 262 per lakhs of population (rural), 
                               334 to 424 per lakhs of population (urban). 
Incidence of stroke   -  119 to 145 per lakhs of population 
Cases fatality rates    -  around 25% (urban ), 37% (rural population)  
    are died due to stroke and its complication in  
    the first 28 days of stroke.  
Mortality rate is highest in Kolkata studies 
(mortality rate –42%). 
IV thrombolysis  
of stroke       - 11% of the stroke. 
Subtypes of Stroke   -  68% cerebral infarct, 32% cerebral  
    hemorrhage.7 
SUBTYPES OF STROKE IN VARIOUS INCIDENCE STUDIES 
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             Stroke ranks first among all neurological disease of adult life. 
Stroke presents with relatively sudden onset of neurological deficit. 
Stroke divided into two types – ischemic or hemorrhagic stroke. Ischemic 
stroke - as a result of occlusion of cerebral blood vessel which leads to 
cerebral ischemia and infarction. 
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Further classification of Ischemic stroke is based on underlying 
cause of vascular occlusion. Based on the cause, ischemic stroke, can 
arises from (1) large cerebral blood vessels atherosclerosis with 
superimposed thrombus, (2) small cerebral vessel occlusion in brain 
parenchyma, (3) cerebral embolism. Other causes includes arterial 
dissection, vasculitis, vasospasm, hyper-coagulable state, cortical vein 
thrombosis. 
The other category consist of hemorrhage which may be 
intracerebral hemorrhage(ICH) or subarachnoid hemorrhage(SAH).The 
main causes of ICH are hypertension, coagulopathies, head trauma, 
vascular malformations, hemorrhagic transformation of ischemia. The 
most common cause of SAH is rupture of aneurysm of cerebral vessels of 
circle of willis. Other cause are head trauma, AV malformations.  
Transient ischemic attack (TIA)- defined as temporary neurological 
deficit which recovers completely within 24 hours without any recidual 
deficit and with normal brain imaging.8 
STROKE –RISK FACTORS 
FIXED RISK FACTORS 
A. Age  - elderly are more at risk. After 55 years, risk doubles for 
every decade.19 
B. Sex –male are at more risk than female except at extremes of age 
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C. Heriditary/Genetic factors 
D. Race - Afro Carrribeans> Asians > Europeans 
MODIFABLE RISK FACTORS 
A. Hypertension - the most important risk factor. 
B. Diabetes mellitus - it increases stroke incidence by 1.8 to 3.5 times. 
Hyperglycemia and insulin resistance are very important risk 
factors.9 
C. Hyperlipidaemia 
D. Cigarette smoking - risk doubling is seen in heaviest of smokers.20 
E. Excessive  alcohol intake 
F. Obesity 
G. Heart disease 
AF(Atrial fibrillation) 
CCF(Congestive cardiac failure) 
Infective endocarditis 
H. Oestrogen containing drugs 
(OCP, Hormone replacement therapy) 
 
19 
 
 
INCIDENCE OF RISK FACTORS IN VARIOUS TYPE OF STROKE (%) 
 
HSR-Harvard stroke registry, MRSR-Michael Reese stroke registry,                             
T-thrombosis,      Lac-Lacune,                 Emb-embolism 
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         WEIGHTING OF VARIOUS ECOLOGICAL FACTORS1 
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CEREBROVASCULAR DISEASE AT DIFFERENT AGE3 
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CLASSIFICATION OF STROKE 
BASED ON PATHOGENESIS: 
A) Ischemic stroke 
          B) Hemorrhagic stroke 
          C) Stroke of undetermined origin 
  
 
A) ISCHEMIC STROKE 
a) Thrombosis 
Large vessels disease 
   lacunar stroke (small Vessels) 
Dehydration 
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b) Embolic Occlusion 
i. Cardio –embolic 
            a. Myocardial infarction (MI) 
                     b. Mural thrombus 
                     c . Atrial fibrillation (AF) 
ii. Dilated cardiomyopathy (DCM) 
c) Valvular lesions 
i. Prosthetic valves 
           ii. Mitral  stenosis  
           iii. Bacterial  Endocarditis 
           iv. Atria septal aneurysm 
           v. Spontaneous ECHO contrast 
           vi. Paradoxical embolus: 
            Patent Foramen  ovale,  Atrial septal  defect (ASD) 
d)   Artery to Artery 
Aortic arch 
           Carotid artery bifurcation 
           Arterial dissection 
e)     Cardiogenic 
i  Marantic  Endocarditis 
           ii. Libman sacks Endocarditis 
           iii. Intracardiac mass 
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           iv. Mitral valve calcification 
           v. Atrial myxoma 
f)   Vasculitis 
i. Primary CNS vasculitis 
           ii. Systemic Vasculitis – 
            1.Wegener’sGranulomatosis 
                     2.Polyarteritis nodasa (PAN) 
                     3.Takayasu arteritis 
                     4. Giant cell arteritis 
g)    Meningitis 
(TB, syphilis, bacterial, fungal, Bacterial, Zoster) 
h)      Hypercoagulable disorders 
Antiphospholipid Antibody Syndrome 
Protein C,S deficiency 
           Antithrombi III deficiency 
           Prothrombin v G20210 mutation 
           Systemic lupus erythematosis(SLE) 
           Thrombotic thrombocytopenic Purpura (TTP) 
Disseminated Intravascular Coagulation (DIC) 
Systemic Malignancy 
           Inflammatory bowel disease (IBD) 
OralContraceptive pills(OCP) 
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            Homocysteinemia. 
                     Dysproteinemias 
i)     Eclampsia 
j)     Drugs –cocaine, Amphetamine 
 
B) HEMORRHAGIC STROKE 
1. hypertension 
           2. rupture of cerebral aneurysm 
           3. head trauma 
           4. blood  dyscrasias 
           5. drug induced ( anticoagulation therapy or thrombolytic therapy) 
           6. bleeding in the brain tumors 
           7. miscellaneous  cause 
C) STROKE OF UNDETERMINED ORIGIN 
1. leukariosis 
           2. aortic arch syndrome 
           3. Fibromuscular dysplasia 
           4. Binswanger’s disease 
           5. moyamoya disease 
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CLINICAL CLASSIFICATION 
           (1) Based on arterial territory involved 
  (a) Anterior circulation stroke: 
                      It may be 
                               - Anterior cerebral artery (ACA) syndrome 
                               - Middle cerebral artery (MCA) syndrome 
 (b) Posterior circulation stroke: 
                      It may be 
- Vertebro basilar artery syndrome 
                               - Posterior cerebral artery syndrome 
(2) Based on clinical manifestations: 
            (a)  completed stroke: 
It is rapid onset of stroke, with persistent neurological 
deficit but it does not progress beyond 96 hours.3 
(b) Evolving stroke : 
                       In this type, there is stuttering or gradual  
  development of deficit 
c) Reversible ischemic neurological deficit : 
                      There will be neurological deficit but there will be  
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  complete recovery within one week. 
                     d) Transient ischemic attack (TIA): 
                       TIA refers to focal neurological deficit which  
  completely recovers within 24 hours. 
                                            
                           STROKE
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PATHOGENESIS OF DIFFERENT TYPES OF ISCHEMIC STROKE 
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PATHOPHYSIOLOGY OF STROKE 
CEREBRAL AUTOREGULATION 
Cerebral blood flow normally depends on the amount of  resistance 
of cerebral blood vessels, which depends on their circumference.10 
Cerebral blood vessels  dilatation leads to increased  amount of cerebral 
blood flow, while constriction  has  opposite effect. Cerebral blood flow 
was also determined by the cerebral perfusion pressure. 
Cerebral autoregulation is the maintainence of constant blood flow 
inspite of changes in the perfusion pressure of brain. There are three 
mechanism which are thought to responsible for cerebral autoregulation. 
They are metabolic, myogenic, neurogenic. 
Metabolic regulation is by the balance between the demand and 
oxygen supply through cerebral blood flow and it acts through vasoactive 
substance. It acts through negative feedback system. 
Myogenic regulation –the transmural blood pressure are detected 
by smooth muscle in the arteriole and they are adjusted to keep constant 
blood flow. 
Neurogenic regulation is by sympathetic innervations which 
controls the resistance in arterioles. Parasympathetic fibers which release 
nitric oxide also plays role. 
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Cerebral blood flow is maintained by cerebral autoregulation 
within a range of 60 to 150 mmHg of MAP (mean arterial Pressure). The 
limits may vary but beyond this range of mean arterial pressure, the brain 
will be unable to compensate for the perfusion pressure changes, and 
hence cerebral blood flow increases or decreases passively according to 
the corresponding changes in pressure, resulting in the risk of ischemia 
when there is low pressures and edema occurs at high pressures. 
 
CEREBRAL AUTOREGULATION DURING STROKE 
Cerebral auto regulation will get impaired in some diseases 
including ischemic stroke.11,12 When perfusion pressure of brain  
decreased there will be compensatory cerebral vascular dilatation leading 
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to increased flow. When the autoregulation fails, when it falls below the 
compensatory ability of the brain then there will be decrease in the 
cerebral blood flow. Initially, there will be increase in the extraction 
fraction of the oxygen so that there will be maintenance in the level of 
oxygen supply to the brain. When there is continuous fall in the cerebral 
blood flow, other mechanisms come into play. 
                     In hypertensive patient, cerebral auto regulation occurs at 
higher arterial pressures. So on suddenly reducing the blood pressure to 
normal levels in ischemic stroke would exacerbate the derangement of  
autoregulation  which would lead to further decrease in cerebral blood 
flow.So it is safe to modestly decrease blood pressure in patient with 
acute ischemic stroke. There are no data on controlled trial to indicate 
decreasing blood pressure is beneficial in acute  ischemic stroke. In 
patient with acute ischemic stroke, blood pressure should be decreased 
when there is malignant hypertension, concomitant  myocardial ischemia, 
blood pressure >185/110mmhg and there is anticipation of thrombolytic 
therapy. 
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EFFECT OF DECREASED CEREBRAL BLOOD FLOW ON 
VITAL BRAIN FUNCTIONS          
 
CONSEQUENCES OF REDUCTION IN BLOOD FLOW 
DURING STROKE 
The human brain is more sensitive to ischemia even on short 
durations. Among the cardiac output, 20% is received by the brain. 
The human brain has no own energy stores, so it completely 
depend on the blood flow for their delivery.Hence even brief deprivation  
in flow leads to death of the brain tissue affected. Reduction of cerebral 
blood flow results in a deprivation of oxygen and glucose during stroke. 
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In ischemic stroke .when the blood vessel is affected, the area 
which is supplied by the vessel, that is immediately surrounding the 
vessel get involved earlier. In this area if there is prolonged ischemia. 
then there will be death of the cells by necrosis. This area which 
underwent necrosis is known as cerebral infarct. The pheripheral area 
which receives blood flow-nutrients and oxygen through collaterals, will 
not die immediately and it can be revived by restoration of blood flow by 
timed intervention.24This area surrounding the dead cells is known as  
Ischemic penumbra.1 
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The possible sequence of events in cerebral ischemia are 
                       Depletion of ATP 
                         Sodium, potassium, calcium ionic concentration changes 
                       Acidosis due to increased amount of lactic acid 
                       Oxygen free radicals 
                       Proteolytic enzymes 
                       Accumulation of water inside the cell 
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CASCADE OF CEREBRAL ISCHEMIA 
                 
 
                            
CEREBRAL EDEMA 
Cerebral edema in stroke can cause numerous secondary damages 
in brain-increasing intracranial pressure which leads to decreased cerebral 
blood flow and other is mass effect  which causes herniation which may 
be life threatening. 
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In ischemic stroke two types of edema can occur. 
1.cytotoxic edema 
          2.vasogenic edema 
 
CYTOTOXIC EDEMA 
Due to ischemia, there will be failure of energy dependent pumping 
system of sodium and calcium, which will lead to accumulation of water 
inside the cells resulting in cerebral edema21,22,23 .Cytotoxic edema 
implies large volume of dying or dead cells implies poor outcome. 
 
VASOGENIC EDEMA 
The blood brain barrier breakdown occurs, resulting in leakage of 
osmotically active substance from intravascular to interstitial space which 
results in increased extracellular fluid volume.It does not necessarily 
implies neuronal injury and this extravascular fluid can be mobilized and 
removed.1 
About 10% of ischemic stroke is massive because of this cerebral 
edema which may be severe to produce increased intracranial tension and 
herniation. 
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STROKE SYNDROMES BASED ON ARTERIAL TERITORRY 
INVOLEMENT 
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LACUNAR STROKE 
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IMAGING STUDIES 
CT SCAN 
It helps in differentiation of infarct and hemorrhages. Infarct is 
seen as hypodense lesion whereas hemorrhage is seen as hyperdense area. 
Hypodense marking of involved vein, grey enhancement, post contrast 
enhancement of the involved vein suggest cortical venous thrombosis. 
 
MERITS 
- helps in differentiating infarct and hemorrhages and hence line of 
management can be decided. 
- highly sensitive in detecting SAH. 
 
DEMERITS 
- In acute setting it may not detect infarct in the first 24 hours 
- it may miss cortical surface small infarct. 
- not detect lesion in posterior fossa  due to artifact.    
MRI SCAN 
- It is more sensitive for early brain infarction. 
- it  is considered superior to ct scan for detecting posterior fossa and 
cortical infarction.                                  
- MR Angiogram helps in detecting stenosis of intracranial vessels                                                             
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FINDINGS OF CT IN CEREBRAL INFARCTION 25 
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FINDINGS OF MRI  IN CEREBRAL INFARCTION 
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TREATMENT OF ACUTE ISCHEMIC STROKE 
MEDICAL SUPPORT 
Blood pressure should be lowered 13 
- when BP >185/110mmHg,thrombolytic therapy anticipated. 
- malignant hypertension 
- concomitant myocardial ischemia  
Serum glucose should be maintained and kept below180mg/dl, if needed 
by insulin infusion.13 
Fever will be detrimental, should be lowered by surface cooling and 
antipyretics.14 
For cerebral edema, iv mannitol, water restriction can be tried. But 
hypovolemia should be avoided. 
INTRAVENOUS THROMBOLYSIS 
INDICATIONS 13 
Clinical diagnosis of stroke 
          Time between symptoms and drug administration<=4.5hrs 
          Age >=18yrs 
          No hemorrhage in CT and edema <1/3 of MCA Territory 
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IV THROMBOLYSIS 3 
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ANTITHROMBOTIC TREATMENT 
PLATLET INHIBITION 
           Aspirin is the only agent which was effectively proven for acute 
ischemic stroke.17Clopidogrel is under trial for preventing stroke 
following TIA.It can be given to patients who show resistance to 
aspirin.18 
ANTICOAGULATION 
            Anticoagulation has no benefit for atherothrombotic stroke and 
also it increases risk of hemorrhage.16It is useful in cortical venous 
thrombosis and in patient with atrial fibrillation. 
ENDOVASCULAR TECHNIQUE 
NEUROPROTECTION 
STROKE CENTRES AND REHABILITATION 
- Physical,occupational,speech therapy 
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ALGORITHM FOR  STROKE MANAGEMENT13
 
  
48 
 
ROLE OF CALCIUM IN ISCHEMIC STROKE         
Calcium ions play a important physiological role in the 
pathophysiology of cerebral ischemia. It has been studied with its 
relationship with stroke incidence and risk factors of stroke. It has been 
demonstrated that in cerebral ischemia, there is decrease in calcium.  
It has also been demonstrated that disturbed calcium homeostasis and to 
events such as proteolysis and lipolysis which are calcium triggered 
events are related to gross brain damage, involving edema and  
infarction. 27   
Cell calcium (ca2+) metabolism which occurs during and 
immediately after a transient period of ischemia influences the sequence 
of events that leads to subsequent progressive neuronal injury. For 
instance, ischemia and hypoxia, causes rapid translocation of calcium( 
Ca2+) from extracellular spaces to intracellular spaces of brain tissues . 
This intracellular Ca accumulation leads to various neuronal damage by 
triggering the multiple cycle of cytotoxic events. 
A coupling exists between the influx of calcium into cells and the 
subsequent production of reactive oxygen species-free radicals. 
Mitochondrial  accumulation of calcium and oxidative stress can trigger 
the opening of a high-conductance pore which is present in the inner 
mitochondrial membrane.29 This mitochondrial permeability transition 
(MPT) pore leads to a collapse of the electrochemical potential for 
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hydrogen ions( H+), thereby leads to arrest of ATP production and it 
triggers the production of reactive oxygen species.29 
 
              Calcium plays a important role in the physiology, biochemistry 
of cell. It also plays an vital role in signal transduction pathways and it 
acts as a second messenger. Numerous enzymes require calcium ions as a 
cofactor as that of blood-clotting cascade26 . Extracellular calcium is very 
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important for proper maintenance of the potential difference across the 
excitable cell membranes. 
Many studies has been done and found that higher level of serum 
calcium levels at the time of admission are associated with smaller 
cerebral infarct volumes in patients  affected with acute ischemic stroke.28 
 
SERUM ALBUMIN IN ACUTE ISCHEMIC STROKE 
Human serum albumin acts as a unique multifunctional protein 
with marked neuroprotective properties.30 Albumin has numerous 
intravascular effects. It reduces hematocrit level, influences aggregation 
of erythrocyte by increasing low shear viscosity, decreasing 
sedimentation of erythrocyte under no flow conditions. 
                Albumin acts as a major antioxidant defense against oxidizing 
agents. The neuroprotective property of human albumin in ischemic 
stroke also resides  in its effect of antagonism of stagnation, thrombosis, 
adhesion of leucocyte within postcapillary microcirculation . 
           Many experimental animal studies has been done and it showed 
that human albumin therapy in acute stroke improves neurological 
function and markedly reduces the volume of cerebral infarction, 
decreases brain swelling in animals31. Many human studies has been done 
and it showed that high serum albumin level  is associated with decreased  
poor outcome in acute ischemic stroke.32 
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NATIONAL INSTITUTE OF HEALTH STROKE SCALE (NIHSS) 
NIHSS was developed to assess the severity of stroke.It comprises 
totally of 11 items. Maximum possible score 42. 
                       
               SCORE                                 STROKE SEVERITY 
                    0   NO STROKE SYMPTOMS 
                  1-4   MINOR STROKE 
                5-15   MODERATE STROKE 
              16-20   MODERATE-SEVERE STROKE 
              21-42   SEVERE STROKE 
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NIHSS 
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MODIFIED RANKIN SCALE  (MRS) 
TOTAL SCORE  0-6 
 
 
 
 
MATERIALS AND METHODS 
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MATERIALS AND METHODS 
SETTING 
This study was conducted at the Institute of Internal Medicine, 
Rajiv Gandhi Government General Hospital (RGGGH), Madras Medical 
College, Chennai. 
 
ETHICAL COMMITTEE APPROVAL 
Obtained 
 
STUDY DURATION 
This study was conducted over a period of six months. 
 
STUDY POPULATION 
Patients who are admitted with Acute ischemic stroke to the 
medical wards at the Institute of Internal Medicine. 
 
SAMPLE SIZE 
70 Patients 
 
TYPE OF STUDY 
Observational study 
 
INCLUSION CRITERIA 
Patients 
Age 18-60 yrs 
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          Those with Acute ischemic stroke within 48 hrs of  presentation. 
  
EXCLUSION CRITERIA 
Age > 60 yrs 
          Hemorrhagic stroke 
          Those presenting with ischemic stroke after 48 hrs of onset 
          Chronic renal failure 
          Hepatic failure 
          Recent myocardial infarction 
          Congestive cardiac failure 
          Cardiac arrhythmia 
          Fever/recent infection 
          Uncontrolled DM 
           Recurrent CVA 
           Those on calcium supplementation or on drugs affecting serum 
calcium. 
            Malignancy 
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DATA COLLECTION AND METHODS 
On patients who have been admitted in medicine ward, RGGGH, 
Chennai, an observational study on acute ischemic stroke patients for 
period of 6 months. Patients selected for clinical study as per inclusion 
and exclusion criteria. Detailed history taking and clinical examination 
will be done. Serum levels of calcium and albumin will be estimated. 
          Severity of stroke will be assessed using National Institute of 
Health Stroke Scale(NIHSS) and one week functional outcome was 
assessed using modified rankin scale(mRS). 
      Patients were classified in to four quartiles based on corrected 
serum calcium as C1, C2, C3, C4 and based on serum albumin as A1, A2, 
A3, A4. 
CALCIUM QUARTILES              CORRECTED CALCIUM 
        C1                                               <=8.59 mg/dl 
        C2                                              8.60-8.99 mg/dl 
        C3                                              9.0-9.39 mg/dl 
        C4                                              >9.40 mg/dl 
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ALBUMIN QUARTILES                   SERUM ALBUMIN 
         A1                                                < 3.49 mg/dl 
     A2                                                3.50-3.99 mg/dl 
     A3                                                4.00-4.49 mg/dl 
     A4                                                  >4.5 mg/dl 
 
NIHSS -Totally 11 items, maximum possibility score  42 
MODIFIED RANKIN SCALE-  0-6 
 
Corrected Serum calcium and serum albumin were correlated with 
severity and outcome  of acute ischemic stroke by NIHSS and mRS scale.    
 
All the data obtained were entered in the proforma(enclosed). 
 
Data were analyzed using  SPSS package  and by chi-square tests, 
ANOVA. 
     
                       
           
 
 
 
 
 
OBSERVATIONS AND RESULTS  
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AGE DISTRIBUTION 
 
                                      
 
 
 
 
 
 
 
   
            
  
Age in years
51-6041-50Below 40
N
o
.
 
o
f P
at
ie
n
ts
40
30
20
10
0
AGE IN 
YEARS 
NO OF 
PATIENTS 
Percent 
Below 40 12 17.1 
41-50 22 31.4 
51-60 36 51.4 
Total 70 100.0 
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SEX DISTRIBUTION 
          
            
 
 
 
 
                        
 
  
Sex
FemaleMale
N
o
.
 
o
f P
at
ie
n
ts
50
40
30
20
10
0
SEX NO OF PATIENTS Percent 
Male 43 61.4 
Female 27 38.6 
Total 70 100.0 
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NIHSS SCORE AMONG THE STUDY GROUP 
 
 
  
Severe
Moderate severe
Moderate
Minor
NIHSS NO OF PATIENTS Percent 
Minor 
(0-4) 
25 35.7 
Moderate 
(5-15) 
18 25.7 
Moderate severe 
(16-20) 
13 18.6 
Severe 
(21-42) 
14 20.0 
Total 70 100.0 
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MODIFIED RANKIN SCALE AMONG STUDY GROUP 
       
 
 
 
 
      
 
 
 
 
  
Modified Ranking scale
654321
N
o
.
 
o
f P
at
ie
n
ts
18
16
14
12
10
8
6
4
2
0
mRS NO OF PATIENTS Percent 
1 16 22.9 
2 17 24.3 
3 10 14.3 
4 8 11.4 
5 11 15.7 
6 8 11.4 
Total 70 100.0 
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DISTRIBUTION OF PATIENTS IN VARIOUS CALCIUM 
QUARTILES 
         
 
  
C4
C3
C2
C1
QUARTILES 
CORRECTED 
CALCIUM 
(in mg/dl) 
NO OF 
PATIENTS 
Percent 
C1 <=8.59 18 25.7 
C2 8.60-8.99 16 22.9 
C3 9.0-9.39 17 24.3 
C4 >=9.40 19 27.1 
Total  70 100.0 
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DISTRIBUTION OF PATIENTS IN VARIOUS ALBUMIN 
QUARTILES 
 
 
 
  
A4
A3
A2
A1
ALBUMIN 
QUARTILES 
SERUM 
ALBUMIN 
(in mg/dl) 
NO OF 
PATIENTS 
Percent 
A1 <=3.49 20 28.6 
A2 3.50-3.99 17 24.3 
A3 4.00-4.49 15 21.4 
A4 >=4.5 18 25.7 
Total  70 100.0 
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HYPERTENSION AMONG STUDY POPULATION 
 
HYPERTENSION 
NO OF 
PATIENTS 
Percent 
Yes 44 62.9 
No 26 37.1 
Total 70 100.0 
 
 
DIABETES MELLITUS AMONG STUDY POPULATION 
 
DIABETES 
MELLITUS 
NO OF 
PATIENTS 
Percent 
Yes 31 44.3 
No 39 55.7 
Total 70 100.0 
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MEAN AGE DISTRIBUTION IN DIFFERENT CALCIUM 
QUARTILES 
              
MEAN AGE DISTRIBUTION IN DIFFERENT ALBUMIN 
QUARTILES 
  
S.NO CALCIUM 
QUARTILES 
NO OF 
PATIENTS 
MEAN AGE 
(YEARS) 
 
 
 
p value 
0.966 
Not 
significant 
1 C1 18 49.06 
2 C2 16 49.63 
3 C3 17 48.59 
4 C4 19 48.21 
 Total 70 48.84 
S.NO 
ALBUMIN 
QUARTILES 
NO OF 
PATIENTS 
MEAN AGE 
(YEARS) 
 
p value 
0.955 
Not 
significant 
1 A1 20 49.30 
2 A2 17 48.65 
3 A3 15 49.47 
4 A4 18 48.00 
 Total 70 48.84 
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MEAN SEX DISTRIBUTION IN DIFFERENT CALCIUM 
QUARTILES 
 
 
 
Corrected Serum Calcium
C4C3C2C1
Co
u
n
t
14
12
10
8
6
4
Sex
Male
Female
  Sex Total  
 
 
 
 
 
P value 
0.821 
Not 
significa
nt 
  Male Female  
Correct
ed 
Serum 
Calciu
m 
C1 NO OF 
PATIENTS 
11 7 18 
  % within Sex 25.6% 25.9% 25.7% 
 C2 NO OF 
PATIENTS 10 6 16 
  % within Sex 23.3% 22.2% 22.9% 
 C3 NO OF 
PATIENTS 9 8 17 
  % within Sex 20.9% 29.6% 24.3% 
 C4 NO OF 
PATIENTS 13 6 19 
  % within Sex 30.2% 22.2% 27.1% 
Total NO OF 
PATIENTS 43 27 70 
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MEAN SEX DISTRIBUTION IN DIFFERENT ALBUMIN 
QUARTILES 
 
    Sex Total  
 
 
 
 
 
P value 
0.698 
Not 
significa
nt 
    Male Female  
Serum 
Albumin 
A1 NO OF 
PATIENTS 12 8 20 
    % within Sex 27.9% 29.6% 28.6% 
  A2 NO OF 
PATIENTS 9 8 17 
    % within Sex 20.9% 29.6% 24.3% 
  A3 NO OF 
PATIENTS 9 6 15 
    % within Sex 20.9% 22.2% 21.4% 
  A4 NO OF 
PATIENTS 13 5 18 
    % within Sex 30.2% 18.5% 25.7% 
Total Count 43 27 70 
 
 
  
Serum Albumin
A4A3A2A1
Co
u
n
t
14
12
10
8
6
4
Sex
Male
Female
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PATIENTS WITH HYPERTENSION IN DIFFERENT  
CALCIUM QUARTILES 
 
 
  
  Hypertension Total  
 
 
 
 
 
 
 
 
P value 
0.782 
Not 
significant 
  Yes No  
Corrected 
Serum 
Calcium 
C1 NO OF 
PATIENTS 12 6 18 
  % within 
Hypertension 
27.3% 23.1% 25.7% 
 C2 NO OF 
PATIENTS 
10 6 16 
  % within 
Hypertension 
22.7% 23.1% 22.9% 
 C3 NO OFNTS 
PATIE 
9 8 17 
  % within 
Hypertension 
20.5% 30.8% 24.3% 
 C4 NO OF 
PATIENTS 
13 6 19 
  % within 
Hypertension 
29.5% 23.1% 27.1% 
Total NO OF 
PATIENTS 
44 26 70 
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PATIENTS WITH DIABETES MELLITUS IN DIFFERENT 
CALCIUM QUARTILES 
 
    Diabetes Mellitus Total  
 
 
 
 
 
p value 
0.778 
Not 
significa
nt 
    Yes No  
Correcte
d Serum 
Calcium 
C1 NO OF 
PATIENTS 8 10 18 
  % within Diabetes 
Mellitus 
25.8% 25.6% 25.7% 
 C2 NO OF 
PATIENTS 
7 9 16 
  % within Diabetes 
Mellitus 
22.6% 23.1% 22.9% 
 C3 NO OF 
PATIENTS 
6 11 17 
  % within Diabetes 
Mellitus 
19.4% 28.2% 24.3% 
 C4 NO OF 
PATIENTS 
10 9 19 
  % within Diabetes 
Mellitus 
32.3% 23.1% 27.1% 
Total NO OF 
PATIENTS 
31 39 70 
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PATIENTS WITH HYPERTENSION IN DIFFERENT ALBUMIN 
QUARTILES 
 
  Hypertension Total  
 
 
 
 
 
p value 
0.489 
Not 
significa
nt 
    Yes No   
Serum 
Albumin 
A1 NO OF PATIENTS 
13 7 20 
  % within 
Hypertension 
29.5% 26.9% 28.6% 
 A2 NO OF PATIENTS 11 6 17 
  % within 
Hypertension 
25.0% 23.1% 24.3% 
 A3 NO OF PATIENTS 7 8 15 
  % within 
Hypertension 
15.9% 30.8% 21.4% 
 A4 NO OF PATIENTS 13 5 18 
  % within 
Hypertension 
29.5% 19.2% 25.7% 
Total NO OF PATIENTS 44 26 70 
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PATIENTS WITH DIABETES MELLITUS IN DIFFERENT 
ALBUMIN QUARTILES 
 
  Diabetes Mellitus Total  
 
 
 
 
 
 
 
 
 
 
 
p value 
0.841 
Not 
significan
t 
  Yes No  
Serum 
Albumin 
A1 NO OF 
PATIENTS 
9 11 20 
  % within 
Diabetes 
Mellitus 
29.0% 28.2% 28.6% 
 A2 NO OF 
PATIENTS 
6 11 17 
  % within 
Diabetes 
Mellitus 
19.4% 28.2% 24.3% 
 A3 NO OF 
PATIENTS 
7 8 15 
  % within 
Diabetes 
Mellitus 
22.6% 20.5% 21.4% 
 A4 NO OF 
PATIENTS 
9 9 18 
  % within 
Diabetes 
Mellitus 
29.0% 23.1% 25.7% 
Total NO OF 
PATIENTS 
31 39 70 
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CALCIUM QUARTILE DISTRIBUTION ACCORDING TO NIHSS 
 
  NIHSS Total  
 
 
 
 
 
 
 
 
p value 
 
<0.001 
 
Highly 
signific
ant 
 
 
 
 
  
Minor 
(0-4) 
Mode
rate 
(5-15) 
Moderat
e severe 
(16-20) 
Severe 
(21-42)  
Correcte
d Serum 
Calcium 
C
1 
NO OF 
PATIENTS 0 4 6 8 18 
  % within 
NIHSS 
.0% 
22.2
% 
46.2% 57.1% 
25.7
% 
 C
2 
NO OF 
PATIENTS 
3 4 6 3 16 
  % within 
NIHSS 
12.0
% 
22.2
% 
46.2% 21.4% 
22.9
% 
 C
3 
NO OF 
PATIENTS 
12 3 1 1 17 
  % within 
NIHSS 
48.0
% 
16.7
% 
7.7% 7.1% 
24.3
% 
 C
4 
NO OF 
PATIENTS 
10 7 0 2 19 
  % within 
NIHSS 
40.0
% 
38.9
% 
.0% 14.3% 
27.1
% 
Total NO OF 
PATIENTS 
25 18 13 14 70 
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ALBUMIN QUARTILE DISTRIBUTION ACCORDING TO NIHSS 
 
  
  NIHSS Total  
 
 
 
 
 
 
 
 
p value 
<0.001 
Highly 
signific
ant 
  
Minor 
(0-4) 
Moder
ate 
(5-15) 
Moderate 
severe 
(16-20) 
Severe 
(21-42)  
Serum 
Album
in 
A1 NO OF 
PATIEN
TS 
0 5 6 9 20 
  % within 
NIHSS .0% 27.8% 46.2% 64.3% 
28.6
% 
 A2 NO OF 
PATIEN
TS 
5 3 6 3 17 
  % within 
NIHSS 20.0% 16.7% 46.2% 21.4% 
24.3
% 
 A3 NO OF 
PATIEN
TS 
11 3 1 0 15 
  % within 
NIHSS 44.0% 16.7% 7.7% .0% 
21.4
% 
 A4 NO OF 
PATIEN
TS 
9 7 0 2 18 
  % within 
NIHSS 36.0% 38.9% .0% 14.3% 
25.7
% 
Total NO OF 
PATIEN
TS 
25 18 13 14 70 
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CALCIUM QUARTILE DISTRIBUTION ACCORDING TO 
MODIFIED RANKIN SCALE 
COR
RECT
ED 
SERU
M 
CAL
CIUM 
 Modified Ranking scale Total  
 
 
 
 
 
 
 
 
 
 
p 
value 
0.001 
Highly 
signifi
cant 
 1 2 3 4 5 6  
C1 NO OF 
PATIEN
TS 
0 1 2 4 5 6 18 
 % within 
Modified 
Ranking 
scale 
.0% 5.9% 20.0% 50.0% 45.5% 75.0% 25.7% 
C2 NO OF 
PATIEN
TS 
2 4 1 2 5 2 16 
 % within 
Modified 
Ranking 
scale 
12.5
% 23.5% 10.0% 25.0% 45.5% 25.0% 22.9% 
C3 NO OF 
PATIEN
TS 
6 5 4 1 1 0 17 
 % within 
Modified 
Ranking 
scale 
37.5
% 29.4% 40.0% 12.5% 9.1% .0% 24.3% 
C4 NO OF 
PATIEN
TS 
8 7 3 1 0 0 19 
 % within 
Modified 
Ranking 
scale 
50.0
% 41.2% 30.0% 12.5% .0% .0% 27.1% 
TOT
AL 
NO OF 
PATIEN
TS 
16 17 10 8 11 8 70 
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ALBUMIN QUARTILE DISTRIBUTION ACCORDING TO 
MODIFIED RANKIN SCALE 
 
SERUM 
ALBU
MIN 
 Modified Ranking scale Total 
 
 
 
 
 
 
 
 
 
 
 
p 
value 
0.002 
Highl
y 
signif
icant 
 
 
 
 
 
 
  1 2 3 4 5 6  
A1 
NO OF 
PATIENT
S 
0 2 2 4 6 6 20 
 
% within 
Modified 
Ranking 
scale 
.0
% 
11.8
% 
20.0
% 
50.0
% 
54.5
% 
75.0
% 
28.6
% 
A2 
NO OF 
PATIENT
S 
4 3 1 2 5 2 17 
 
% within 
Modified 
Ranking 
scale 
25
.0
% 
17.6
% 
10.0
% 
25.0
% 
45.5
% 
25.0
% 
24.3
% 
A3 
NO OF 
PATIENT
S 
5 5 4 1 0 0 15 
 
% within 
Modified 
Ranking 
scale 
31
.3
% 
29.4
% 
40.0
% 
12.5
% .0% .0% 
21.4
% 
A4 
NO 
OFPATIE
NTS 
7 7 3 1 0 0 18 
 
% within 
Modified 
Ranking 
scale 
43
.8
% 
41.2
% 
30.0
% 
12.5
% .0% .0% 
25.7
% 
TOTAL 
NO OF 
PATIENT
S 
16 17 10 8 11 8 70 
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RESULTS 
AGE DISTRIBUTION 
            In our study, mean age group is 48.84 years. About 17% of  
patients are below age 40.About 31% of patients are between  age 41-
50.About 51% of patients are between 51-60. 
SEX DISTRIBUTION  
             In our study, about 61.4% are male and about 38.6% are about 
female. 
NIHSS DISTRIBUTION 
                  About 35.7% belong to NIHSS grade minor. 
                  About    25.7% of patients belong to moderate. 
                   About 18.6% of patients  are moderate severe. 
                   About  20%  belong to severe group. 
 
MRS DISTRIBUTION 
                   In our study,about 22.9% belong to MRS 1.About 24.3% 
belong to MRS 2.About 14.3%-MRS 3.About 11.4% belong to MRS 4. 
About 15.7% belong to MRS 5.About 11.4% of patients belong to    
MRS 6. 
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CORRECTED SERUM CALCIUM DISTRIBUTION 
                   In this study, about 25.7% patients have serum calcium value 
of C1(<=8.59).About 22.9% have serum calcium  C2(8.60-8.99).About 
24.3% of patients have serum Calcium value of C3(9.0-9.39).About 
27.1% have serum calcium of about C4(>9.40) 
SERUM ALBUMIN DISTRIBUTION 
              About 28.6% of patients have serum Albumin value of 
A1(<3.49).About 24.3% have serum Albumin  A2(3.50-3.99). About 
21.4% of patients have serum Albumin value of A3(4.00-4.49).About 
25.7% have serum Albumin of about A4(>4.5). 
CORRELATION OF AGE AND SEX WITH DIFFERENT 
CALCIUM AND ALBUMIN QUARTILES 
               In our study, we analysed the age with different calcium and 
albumin quartiles and p value obtained was insignificant. Sex distribution 
was analysed with different calcium and albumin quartiles and p value 
was insignificant. This shows age and sex has no influence over different 
calcium and albumin quartiles in our study. 
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DISTRIBUTION OF PATIENTS WITH HYPERTENSION ON 
DIFFERENT CALCIUM AND ALBUMIN QUARTILES 
In our study, we analysed the distribution of hypertensive patients 
on calcium and albumin quartiles to find out any significant association 
of hypertension  in different calcium and albumin quartiles  . 
          p value is about 0.782 which is not significant (hypertension on 
different calcium quartiles) and p value is about 0.489 ,not significant 
(hypertension on different albumin quartiles).This shows there is no 
significant association between hypertension on various calcium and 
albumin quartiles. 
DISTRIBUTION OF PATIENTS WITH DIABETES MELLITUS 
ON DIFFERENT CALCIUM AND ALBUMIN QUARTILES 
p value is about 0.778 which is not significant (DM on different 
calcium quartiles). 
p value is0.841 , not significant (DM on different albumin 
quartiles).This shows Diabetes mellitus does not influence the different 
calcium and albumin quartiles. 
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CORRELATION BETWEEN CORRECTED SERUM CALCIUM 
AND NIHSS AND MODIFIED RANKIN SCALE 
In our study, p value between corrected serum calcium and NIHSS 
is <0.001 which is highly significant. 
p value between corrected serum calcium and modified rankin 
scale is 0.001 which is highly significant. 
This shows that lower corrected serum calcium is associated with 
poor prognosis in acute ischemic stroke as indicated by higher scores of 
NIHSS and MRS and higher levels are associated with good outcome. 
CORRELATION BETWEEN SERUM ALBUMIN AND NIHSS, 
MODIFIED RANKIN SCALE 
In our study, p value between serum albumin and NIHSS is 
<0.001, highly significant. p value between serum albumin and MRS is  
0.002 which is highly significant. 
This shows significant association between them. Higher values of 
serum albumin is associated with good outcome in acute ischemic stroke 
as indicated by NIHSS and MRS and lower values associated with higher 
severity of ischemic stroke. 
 
DISCUSSION 
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DISCUSSION 
In this study, 70 patients admitted with acute ischemic stroke in 
RGGGH, Chennai, based on inclusion, exclusion criteria were analysed. 
They were subjected to detailed clinical examination and severity of 
stroke was analysed using NIHSS and one week functional outcome was 
assessed using modified rankin scale. Serum calcium and serum albumin 
were obtained at the time of admission. 
Corrected serum calcium and serum albumin were correlated with 
NIHSS and MRS and p value obtained was statistically significant 
indicating significant association between them. 
SEX 
 In this study, among 70 patients, males are affected more. Males-
61.4% females-38.6%. This was supported by  Gupta A et al 26  where 
incidence in males is 70% and females is 30%.In a study by Sani 
abubakar et al  male-52% and females 48%.In a study by Bruce ovbiagele 
et al 33male 55% female 45%. In study by Gaurav M Kasundra et al males 
58% females 42% 
 
  
84 
 
SAMPLE SIZE 
       In our study we included  70 patients.Study by Gupta A et al include 
50 patients.Study by Gaurav M Kasundra et al includes 50 patients. Study 
by Bruce ovbiagele et al is a large study where 659 patients were 
subjected. 
AGE 
In our study mean age group is 48.84 years.In study by Gupta A et 
al mean age is 62 years.In study by Gaurav M kasundra mean age is 
59.98+/-10.8.In study by Bruce ovbiagele et al mean age is 70+/-10. 
CORRECTED SERUM CALCIUM 
In our study we classified calcium quartiles as C1  <=8.59 ,  C2   
8.60-8.99,   C3 9.0-9.39, C4 >9.40.This was supported by study of Gupta 
A et al. In study by Bruce ovbiagele et al  C1  <8.82,  C2  8.83-9.18,  C3  
9.19-9.49,  C4  >=9.50. In study by Brian H. Buck et al 34  C1 <8.7,  C2  
8.7-8.9,  C3  9.0-9.3, C4 >9.3. 
SERUM  ALBUMIN 
 In this study albumin quartiles are  A1  <3.49,  A2  3.50-3.99,  A3  
4.00-4.49,  A4  >4.5.This was supported by study of Sani Abubakar et al. 
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HYPERTENSION AND DIABETES WITH SERUM CALCIUM 
AND SERUM ALBUMIN 
In our study hypertension and diabetes were correlated with 
corrected serum calcium and serum albumin, p value obtained was not 
significant indicating presence of hypertension and diabetes had no effect 
on calcium and albumin level in this study. This was supported by study 
done by Gupta A et al. 
CORRECTED SERUM CALCIUM WITH NIHSS AND MRS 
In our study corrected serum calcium is correlated with NIHSS and 
MRS, p value obtained was highly significant. This was supported by 
studies of Gupta A et al, Bruce ovbiagele et al, Brian H.Buck  et al. 
SERUM ALBUMIN WITH NIHSS AND MRS 
In this study, serum albumin correlated with NIHSS and modified 
rankin scale,  p value is highly significant.  This was supported by studies 
of  Dziedzic T et al30, Idicula TT et al32, Sani Abubakar et al, .Kasundra G 
et al35, Cho YM et al36. 
 
 
  
CONCLUSION 
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CONCLUSION 
 
 
This study shows that stroke severity and the functional outcome  
differ significantly with different  calcium and albumin quartiles. The 
stroke severity is more at low calcium and low albumin level  than at 
higher calcium and albumin level and also functional outcome in them is 
better when the levels of calcium and albumin are higher. The association 
is independent. This shows that corrected serum calcium and serum 
albumin can be used as a indicator of severity and for predicting 
prognosis in acute ischemic stroke. 
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LIMITATIONS 
 
One of the limitation is sample size which is less and this study 
should be tested in large number of patients. 
 
Extended follow up of patients was not possible.      
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ANNEXURES 
 
 
PROFORMA 
 
NAME :                                       AGE/SEX: 
 
ADDRESS:                                  OCCUPATION: 
 
 
COMPLAINTS: 
 
 
 
PAST  HISTORY: 
 
 
 
PERSONAL  HISTORY: 
 
 
TREATEMENT HISTORY: 
 
 
GENERAL EXAMINATION: 
 
 
VITAL  SIGNS: 
 
 
 
SYSTEMIC EXAMINATION: 
 
CVS: 
 
 
 
RS: 
 
 
ABDOMEN: 
 
CNS: 
 
       GCS: 
 
 
 RIGHT LEFT 
HIGHER MENTAL 
FUNCTIONS 
  
CRANIAL NERVES   
  OLFACTORY 
  OPTIC 
  OCULOMOTOR 
  TROCHLEAR 
  ABDUCENT 
  TRIGEMINAL 
  FACIAL 
 
VESTIBULOCOCHLEAR 
GLOSSOPHARYNGEAL 
VAGUS 
SPINAL ACCESSORY 
HYPOGLOSSAL 
 
MOTOR   
 BULK: UL 
              LL 
  
TONE:  UL 
              LL 
  
POWER:UL 
               LL 
  
REFLEX:UL 
                 LL 
  
PLANTAR   
 
SENSORY EXAMINATON: 
 
 
CEREBELLAR SIGNS: 
 
 
SIGNS OF MENINGEAL IRRITATION: 
 
 
NIHSS SCORE: 
                              
Score  Stroke Severity 
0 No Stroke Symptoms 
1-4 Minor Stroke 
5-15 Moderate Stroke 
16-20 Moderate to Severe Stroke 
21-42 Severe Stroke 
 
 
 
 
 
MODIFIED RANKIN SCALE:       
    The scale runs from 0-6, running from perfect health without 
symptoms to death. 
• 0 - No symptoms. 
• 1 - No significant disability. Able to carry out all usual activities, 
despite some symptoms. 
• 2 - Slight disability. Able to look after own affairs without assistance, 
but unable to carry out all previous activities. 
• 3 - Moderate disability. Requires some help, but able to walk 
unassisted. 
• 4 - Moderately severe disability. Unable to attend to own bodily needs 
without assistance, and unable to walk unassisted. 
• 5 - Severe disability. Requires constant nursing care and attention, 
bedridden, incontinent. 
• 6 - Dead. 
INVESTIGATIONS 
SERUM CALCIUM 
SERUM  ALBUMIN 
C0RRECTED CALCIUM  
           = SERUM CALCIUM +0.8 * (4 – SERUM  ALBUMIN) 
    
 
 
 
  
TURNITIN PLAGIARISM SCREEN SHOT 
 
 
               
 
 
DIGITAL RECEIPT  
    
 
     
     
 
INFORMATION SHEET 
We are conducting a study on “CORRECTED SERUM 
CALCIUM AND SERUM ALBUMIN IN PREDICTING THE 
SEVERITY AND THE SHORT TERM FUNCTIONAL OUTCOME 
IN PATIENTS WITH ACUTE ISCHEMIC STROKE ” among 
patients admitted in EMERGENCY MEDICINE DEPARTMENT in 
Rajiv Gandhi Government General Hospital, Chennai and for that your 
specimen may be valuable to us. 
           The purpose of this study is to assess the ROLE OF CORRECTED 
SERUM CALCIUM AND SERUM ALBUMIN IN PREDICTING THE 
SEVERITY AND SHORT TERM (ONE WEEK) FUNCTIONAL 
OUTCOME IN ACUTE ISCHEMIC STROKE PATIENTS. 
We are selecting certain cases and if you are found eligible, we 
may be using your blood samples to do certain tests which in any way do 
not affect your final report or management. 
The privacy of the patients in the research will be maintained 
throughout the study. In the event of any publication or presentation 
resulting from the research, no personally identifiable information will be 
shared. 
Taking part in this study is voluntary. You are free to decide 
whether to participate in this study or to withdraw at any time; your 
decision will not result in any loss of benefits to which you are otherwise 
entitled. 
The results of the special study may be intimated to you at the end 
of the study period or during the study if anything is found abnormal 
which may aid in the management or treatment 
 
 
Signature of Investigator 
 
Signature of Participant
PATIENT CONSENT FORM 
Study Detail : “CORRECTED SERUM CALCIUM AND SERUM 
ALBUMIN IN PREDICTING THE SEVERITY AND 
THE SHORT TERM FUNCTIONAL OUTCOME IN 
PATIENTS WITH ACUTE ISCHEMIC STROKE” 
Study Centre : Rajiv Gandhi Government General Hospital, Chennai. 
Patient’s Name :  
Patient’s Age :  
Identification 
Number 
:  
Patient may check (√) these boxes 
a) I confirm that I have understood the purpose of procedure for the 
above study. I have the opportunity to ask question and all my 
questions and doubts have been answered to my complete 
satisfaction. ❏ 
b) I understand that my participation in the study is voluntary and that I 
am free to withdraw at any time without giving reason, without my 
legal rights being affected. ❏ 
c) I understand that sponsor of the clinical study, others working on the 
sponsor’s behalf, the ethical committee and the regulatory authorities 
will not need my permission to look at my health records, both in 
respect of current study and any further research that may be 
conducted in relation to it, even if I withdraw from the study I agree 
to this access. However, I understand that my identity will not be 
revealed in any information released to third parties or published, 
unless as required under the law. I agree not to restrict the use of any 
data or results that arise from this study. ❏ 
d) I agree to take part in the above study and to comply with the 
instructions given during the study and faithfully cooperate with the 
study team and to immediately inform the study staff if I suffer from ❏ 
any deterioration in my health or well being or any unexpected or 
unusual symptoms. 
e) I hereby consent to participate in this study. ❏ 
f) I hereby give permission to undergo detailed clinical examination 
and blood investigations as required. ❏ 
 
 
 
SIGNATURE OF INVESTIGATOR                       SIGNATURE/THUMB 
IMPRESSION 
 
STUDY INVESTIGATOR’S     PATIENT’S NAME AND 
NAME:                ADDRESS: 
 
DR.G.DIANA  
MASTER CHART 
 
S.NO AGE SEX HTN DM 
CORRECTED 
CALCIUM  
(mg/dl) 
SERUM ALBUMIN 
(mg/dl) NIHSS 
MODIFIED 
RANKIN 
SCALE 
1 42 MALE YES NO 9.6 5.1 3 1 
2 40 MALE YES NO 8.8 3.7 18 4 
3 58 FEMALE YES NO 9.1 3.6 36 5 
4 58 MALE YES NO 9.22 4 11 2 
5 47 MALE NO YES 9.11 4.2 2 1 
6 48 MALE YES NO 7.8 3 20 5 
7 38 MALE NO NO 8.3 3.16 10 2 
8 53 MALE NO YES 10 4.85 4 2 
9 57 MALE YES NO 9.82 4.65 8 2 
10 51 FEMALE NO YES 9.57 4.6 32 4 
11 47 FEMALE YES NO 7.9 3.1 15 5 
12 53 FEMALE YES YES 10.1 5.2 2 1 
13 46 MALE YES NO 9.45 4.6 30 3 
14 58 MALE YES YES 9.7 4.9 11 2 
15 46 FEMALE YES NO 9.87 4.98 2 1 
16 58 MALE YES YES 8.7 3.52 30 6 
17 25 FEMALE NO NO 9.25 3.9 4 1 
18 47 MALE NO NO 8.64 3.64 20 5 
19 51 FEMALE NO YES 8.9 3.74 10 2 
20 53 FEMALE YES NO 9.3 3.92 4 1 
21 54 MALE NO NO 9.28 4.42 3 1 
22 54 FEMALE YES NO 8.6 3.58 31 6 
23 60 MALE NO YES 8.72 3.5 20 5 
24 47 FEMALE YES NO 8.87 3.9 3 1 
25 42 MALE NO NO 8.68 3.8 12 2 
26 59 FEMALE YES YES 8.62 3.6 17 5 
27 31 MALE NO NO 8.84 3.96 4 2 
28 50 MALE YES YES 8.64 3.74 16 4 
29 58 FEMALE NO YES 8 2.6 38 6 
30 49 FEMALE NO YES 8.98 3.2 9 2 
31 53 MALE YES YES 7.2 2 40 6 
32 54 FEMALE NO NO 8.3 2.84 18 4 
33 47 FEMALE YES NO 9.92 4.92 3 2 
34 38 MALE NO NO 9.43 5.1 7 1 
35 51 MALE YES YES 10.12 4.97 4 2 
36 38 MALE YES NO 9.78 4.98 4 2 
37 57 MALE YES YES 9.47 4.72 13 3 
38 26 FEMALE NO NO 9.18 4.46 18 4 
39 47 MALE NO YES 9.31 4.3 10 3 
40 39 MALE YES NO 8.9 3.88 2 1 
41 60 MALE YES YES 7.1 2.5 36 6 
42 42 MALE YES NO 9.2 4.24 2 1 
43 42 MALE YES NO 8.2 2.8 30 6 
44 59 MALE YES YES 9.14 4.08 4 3 
45 54 MALE YES NO 8.62 3 28 5 
46 44 MALE NO NO 8.4 3.4 8 3 
47 59 MALE YES YES 7.5 2.9 34 6 
48 50 FEMALE YES YES 7 2.72 40 6 
49 48 FEMALE YES NO 9.38 4.12 4 3 
50 51 FEMALE YES NO 8.2 2.5 28 5 
51 48 MALE NO YES 8.2 3.1 20 4 
52 53 FEMALE YES YES 7.8 3.2 17 5 
53 52 FEMALE YES YES 9 4.32 3 1 
54 39 MALE NO NO 9.32 4.1 12 3 
55 53 MALE NO YES 9.2 4.4 3 2 
56 36 MALE YES NO 7.9 2.8 16 4 
57 40 MALE YES NO 8.2 3.2 10 3 
58 55 MALE NO YES 7.3 2.9 31 5 
59 47 FEMALE YES NO 8.1 3.1 18 4 
60 58 FEMALE YES NO 9.3 4.12 4 2 
61 55 FEMALE YES NO 8.78 3.6 19 5 
62 51 MALE YES YES 9.36 4.28 3 2 
63 58 MALE YES YES 8.94 3.84 12 3 
64 28 MALE NO NO 9.92 4.88 2 1 
65 45 FEMALE YES NO 9.41 4.3 14 3 
66 56 FEMALE NO NO 9.06 4.1 3 2 
67 59 MALE YES NO 9.53 4.82 11 2 
68 43 MALE YES NO 9.87 4.99 6 1 
69 52 FEMALE NO YES 10.1 4.28 4 1 
70 52 MALE NO YES 9.67 5 1 1 
